Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis-Reference-Cited by-同舟云学术

Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis

Published:2019-09-30 Issue:16 Volume:8 Page:6933-6944
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gao Yang¹²^ORCID,Wang Peng‐Xiang¹²,Cheng Jian‐Wen¹²,Sun Yun‐Fan¹²,Hu Bo¹²,Guo Wei³^ORCID,Zhou Kai‐Qian¹²,Yin Yue¹²,Li Yuan‐Cheng⁴,Wang Jian¹²,Huang Jun‐Feng⁵,Qiu Shuang‐Jian¹²,Zhou Jian¹²^ORCID,Fan Jia¹²^ORCID,Yang Xin‐Rong¹²^ORCID

Affiliation:

1. Department of Liver Surgery & Transplantation Liver Cancer Institute Zhongshan Hospital Fudan University Shanghai P. R. China

2. Key Laboratory of Carcinogenesis and Cancer Invasion Ministry of Education Shanghai P. R. China

3. Department of Laboratory Medicine Zhongshan Hospital Fudan University Shanghai P. R. China

4. Institutes of Biomedical Sciences Fudan University Shanghai China

5. Department of Intensive Care Medicine Zhongshan Hospital Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2556

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges

3. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review

4. Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma

5. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma;Cancers;2024-04-06

2. A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma;Molecular Therapy - Nucleic Acids;2023-12

3. Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection;BMC Gastroenterology;2023-09-20

4. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis;Critical Reviews in Oncology/Hematology;2023-09

5. Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus;Advances in Therapy;2023-02-20